{"id":"559312-6955","orgnr":"559312-6955","name":"Cellcolabs AB","name_registered_on":"2021-09-30","legal_form":{"code":"AB","name":"Aktiebolag"},"status":"registered","registered_on":"2021-04-16","business_description":"Bolaget ska, direkt eller indirekt genom hel- eller delägda bolag, producera och sälja cellprodukter för användning i samband med behandling av olika sjukdomstillstånd. Bolaget kommer även att bedriva forskning och processutveckling inom cellproduktion. Bolaget får dessutom handla med noterade och onoterade värdepapper.","industries":[{"code":"72101","name":"Bioteknisk forskning och utveckling"}],"postal_address":{"street":"Scheeles väg 5","postal_code":"17165","city":"SOLNA","country":"SE","municipality":{"code":"0184","name":"Solna"},"county":{"code":"01","name":"Stockholms län"}},"registered_office":{"municipality":{"code":"0180","name":"Stockholm"},"county":{"code":"01","name":"Stockholms län"}},"activity_status":"active","employee_class":{"code":"6","name":"50-99 anställda"},"turnover_class":{"code":"7","name":"50 000 - 99 999 tkr","year":2025},"f_tax":"registered","vat":"registered","employer":"registered","registry_source":{"dataset":"bolagsverket_bulkfil","published_on":"2026-11-16"},"annual_reports":[{"from":"2025-01-01","to":"2025-12-31","framework":"K2","signed_on":"2026-05-04","documents":{"annual_report":"/v1/documents/21d5bdc1-81f2-41c1-8131-c24ac18b90d4.xhtml","audit_report":"/v1/documents/e181ea58-b3a8-4e07-aeb0-a3313bd47957.xhtml"},"source":{"dataset":"arsredovisningar","file":"2026/33_2.zip"}},{"from":"2024-01-01","to":"2024-12-31","framework":"K2","signed_on":"2025-05-05","documents":{"annual_report":"/v1/documents/12dfa4e4-ff07-406e-a0e8-65b3f6b544a8.xhtml","audit_report":"/v1/documents/7cbe1104-3ad6-4aad-92c3-c7c40503a62d.xhtml"},"source":{"dataset":"arsredovisningar","file":"2025/25_8.zip"}},{"from":"2023-01-01","to":"2023-12-31","framework":"K2","signed_on":"2024-03-18","documents":{"annual_report":"/v1/documents/8444a629-7840-450f-a90d-a8e9fc4095f3.xhtml","audit_report":"/v1/documents/e934efe7-e3c6-405d-9f39-e956f9314621.xhtml"},"source":{"dataset":"arsredovisningar","file":"2024/25_7.zip"}}],"latest_financials":{"from":"2025-01-01","to":"2025-12-31","scope":"company","currency":"SEK","net_sales":44171039,"other_operating_income":3450509,"operating_profit":-97349938,"profit_after_financial_items":-97587375,"net_profit":-97587375,"total_assets":123895982,"current_assets":115632826,"equity":108758049,"share_capital":65639,"unrestricted_equity":108692410,"current_liabilities":15137933,"tax_liabilities":1268408,"cash":74494626,"staff_costs":71232942,"employees":68,"net_sales_growth":1.893,"source":{"annual_report":"2025-12-31","document":"/v1/documents/21d5bdc1-81f2-41c1-8131-c24ac18b90d4.xhtml"},"anchors":{"cash":{"text":"74 494 626","prefix":"Summa kassa och bank","suffix":"39 921 883"},"current_assets":{"text":"115 632 826"},"current_liabilities":{"text":"15 137 933"},"employees":{"text":"68"},"equity":{"text":"108 758 049"},"net_sales":{"text":"44 171 039"},"operating_profit":{"text":"97 349 938"},"other_operating_income":{"text":"3 450 509"},"profit_after_financial_items":{"text":"97 587 375","suffix":"-91"},"share_capital":{"text":"65 639","prefix":"utgång"},"staff_costs":{"text":"71 232 942"},"tax_liabilities":{"text":"1 268 408"},"total_assets":{"text":"123 895 982","prefix":"TILLGÅNGAR"},"unrestricted_equity":{"text":"108 692 410","prefix":"375"}}},"officers":{"annual_report":"2025-12-31","signed_on":"2026-05-04","signatories":[{"name":"M*****","role":"Ordförande"},{"name":"S*****","role":"Ledamot"},{"name":"E*****","role":"Ledamot"},{"name":"J*****","role":"Ledamot"},{"name":"M*****","role":"Ledamot"},{"name":"R*****","role":"Ledamot"},{"name":"P*****","role":"Verkställande direktör"}],"auditors":[{"name":"S*****","title":"Auktoriserad revisor","firm":"Öhrlings PricewaterhouseCoopers AB"}]}}